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Abstract
Background: There has been a clear increase in HIV-1 infection cases in recent years in Hebei Province, China, and
transmission via blood is one of the risk factors in the early. This article aimed to investigate the HIV infection rate
and control efficiency among the paid blood donor population over a period of 18 years.
Methods: From 1995–2013, HIV/AIDS cases among former blood donors in Hebei Province were registered and
closely monitored to collect data of all-cause mortality, intervention measures to prevent family transmission,
disease transmission between couples as well as between mothers and infants, and HAART therapy outcomes.
Results: A total of 326 cases were identified as directly infected with HIV/AIDS during plasma donation in Hebei
Province. Of these, 146 cases (44.8 %) were identified in the same year as infection; 180 cases (55.2 %) were
identified 1–18 years after infection because they did not participate in the 1995 screening. The final case was
identified in February 2012. By 2013, the mortality rate and survival rate of plasma donor-related HIV/AIDS was 54.9
% and 45.1 %, respectively. The identified transmission rate between couples was 11.3 % (8/71); this rate during the
same year as infection was 3.3 % (1/30), and the rate 4–17 years after HIV infection was 17.1 % (7/41).
Approximately 91.2 % (145/159) of married women of childbearing age did not have children after being informed
of HIV infection. Only 8.8 % (14/159) of these women had children after being informed of HIV infection. The
mother-to-infant transmission rate was 38.5 % (5/13).
The HAART coverage rate has increased from 10.1 % (16/159) in 2003 to 83.6 % (127/152) in 2013. Since 1999, the
HIV mortality rate has trended up; by 2013, the cumulative mortality rate reached 54.9 % (179/326). After HAART
was initiated in China, the death rate decreased to some extent. Second generation transmission (via couple or
mother-to-infant transmission) among blood donor-related HIV cases accounted for approximately 4.0 % (13/326).
All first- or second-generation cases were infected with HIV-1 subtype B.
Conclusions: In this accident of HIV-infection among plasma donors in Hebei Province, a total of 339 direct and
second-generation cases have been identified over 18 years of monitoring. Favorable clinical results have been
achieved using intervention measurements and antiviral therapy.
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Background
In the early 1950s, there were many blood collection sta-
tions throughout the city of Langfang in Hebei Province,
China. These stations were regarded as the blood dona-
tion base to replenish blood supplies for Beijing and
Tianjin. The 1980s saw the introduction of new technol-
ogy to China that enabled single-donor plasma collection.
Following this, plasmapheresis centers were established in
this region and gradually spread to other regions within
Hebei Province, predominantly in towns and villages
where a large number of paid donors could be sourced.
The recruited medical workers generally had little formal
training or background in blood collection. Tragically,
cross-infection frequently occurred during various steps
of plasma isolation, such as during initial blood collection,
plasma separation, and blood cell return to the donor.
The prevalence of hepatitis C, malaria, and HIV/AIDS
among paid donors at these plasmapheresis centers in-
creased beginning in 1985 [1, 2], 1993 [3], and 1995 [4],
respectively. Given the prevalence of cross-infections,
particularly of HIV/AIDS, all plasmapheresis centers
across the entire province were closed. We have moni-
tored HIV/AIDS cases and deaths up to 2013, investigat-
ing rates of family transmission, preventive interventions,
and HAART during the past 18 years. This study was con-
ducted to acquire data on the prevalence of HIV/AIDS




After early cases of HIV-infected plasma donors were
discovered in 1995 in Langfang, physical examinations
were performed and HIV antibody levels measured for
all plasma donors throughout Hebei Province. From 26
November 2004 to 15 February 2005, in compliance with
notification from the General Office of the Ministry of
Health, registration and blood sampling of former paid
blood donors was repeated, so that HIV antibody screen-
ing could be carried out.
Daily surveillance
Through enactment of policies offering freely accessible
voluntary counseling and testing (VCT), expanded testing
within medical institutions, and monitoring the spouses
and children of HIV-positive individuals, infected donors
from the population who did not participate in the initial
HIV antibody screening were identified. These individuals
had not been screened because they had failed to partici-
pate from fear of discrimination; instead, they were
screened during treatment for other diseases. To encour-
age former paid donors to undergo testing, in January
2012, the government enacted a living subsidy policy for
people who acquired HIV via transmission through blood.
Source surveillance
Plasma samples from blood plasma donors between
1990 and 1994 were acquired from serum banks and
screened. The samples included 140 cases collected from
1990 to 1991, 1090 cases from 1992 to 1994, 124 cases
from 1993 to 1994, and 699 cases in June 1994. The
transfusion histories of four HIV cases identified in 1995
were investigated, and recipients of blood from plasma
donors in Hebei Province were retrospectively followed.
Death surveillance
For the identified HIV/AIDS cases, half-yearly follow-up
examinations were conducted. Registered HIV/AIDS
deaths were determined from all-cause mortality (i.e., in-
cluding AIDS and non-AIDS related deaths). A portion
of the paid blood donors from Hebei Province were not
investigated or followed up because they no longer re-
sided in the province. Additionally, some donors were
not tested for HIV, even though they continued to reside
in Hebei. Therefore, it is possible that the number of
HIV infections could be underestimated.
Cases
Blood samples were collected from identified HIV cases.
Blood serum was separated for all samples, for prelimin-
ary screening using enzyme-linked immunosorbent assay
(ELISA). All positive HIV antibody test results were con-
firmed by western blot assay. HIV-positive cases with a
history as former plasma donors and that were con-
firmed by blood tests, excluding other transmission risk
factors, were determined to have been infected via cross-
infection during donation of blood at plasmapheresis
centers in Hebei Province. If these individuals had one
or more AIDS-indicative diseases or a CD4 count <200
cells/mm3, they were diagnosed as plasma donor-related
AIDS cases. For identified cases of HIV/AIDS, spouses
who tested positive for HIV antibody, excluding risk fac-
tors of plasma donation, extramarital sexual behavior,
intravenous drug use, blood transfusion and so on, were
categorized as couple transmission. Female donor-related
HIV/AIDS cases who were pregnant, who had normal va-
ginal delivery, and/or who breastfed after infection, and
whose infants tested positive for HIV antibody 18 months
after birth, excluding other transmission factors, were cat-
egorized as mother-to-infant transmission.
Prophylaxis and treatment
Spouses of all identified plasma donor-related HIV/AIDS
cases were subject to sample collection and testing if
they were married. In cases negative for HIV antibody,
intervention and prevention measures were carried out,
such as provision of condoms as well as dynamic tracing.
All children of female cases had the possibility of
mother-to-infant transmission, and were subject to sample
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collection for further testing. During regular follow-up of
identified HIV-positive individuals, all cases meeting the
diagnostic criteria for AIDS, or with CD4 counts <200
cells/mm3, were treated with highly active antiretroviral
therapy (HAART).
Beginning in 2008, cases with CD4 counts ≤350 cells/
mm3 were also treated with HAART. During the period
1995–2002, HAART was unavailable in China so AIDS
patients did not have the opportunity to receive this
form of therapy. From 2003, the Chinese government
began a policy of providing free HAART, which included
a non-nucleoside reverse transcriptase inhibitor (EFV) and
two types of nucleoside/nucleotide reverse-transcriptase
inhibitor (AZT, 3TC, d4t, ddl) in combination therapy. In
2007, second-line drugs (LPV/r and TDF) were introduced,
which enabled timely replacement of first-line or other
second-line regimens in drug-resistant patients or for those
suffering toxic side effects.
Genotype detection
In seven plasma donor-related HIV cases (designated as
heb0202, heb0203, heb0206, heb0208, heb0209, heb02012,
heb02015), nested PCR was used to amplify the HIV-1
env gene. The amplified products were sequenced and
used to create a phylogenetic tree using the neighbor-
joining method.
Statistics
A database of plasma donor-related HIV/AIDS cases
and their family members was created. Prior to statistical
analysis, the detection data and original records in the
database were checked thoroughly. Follow-up analysis
was performed, if necessary, such that all cases that did
not meet the conditions were excluded; those that met
the conditions were transferred to the final database.
SPSS 15.0 and Excel were used to perform the statistical
analysis. Analyzed data included that of the HIV out-
break and source, annual changes in HIV/AIDS cases,
sexual transmission between couples, and mother-to-
infant transmission and so on.
Ethics statement
All investigations and HIV-1 tests were informed and
voluntary, and participants agreed that their samples
may be used for the purpose of controlling and prevent-
ing HIV. Written informed consent was obtained from
all adult patients and parents/guardians of HIV-1 posi-
tive children in this study. The study was conducted ac-
cording to the Declaration of Helsinki and was approved
by the local Ethics Committee at Hebei Province Centers
for Disease Control and Prevention, ethics board docu-
ment number IRB(P)2014-002.
Results
HIV outbreak and source
In February 1995, a paid plasma donor in Langfang,
Hebei Province was identified as HIV-1 positive during
screening for blood donation at a hospital in Tianjin.
From February to April of 1995, HIV screening of
former paid plasma donors was conducted throughout
Hebei, and the results indicated that the HIV infection
rate was 1.5 % (146/9811) among paid blood donors. In
the same year, all plasmapheresis centers in Langfang
and across Hebei Province were closed. Donors’ blood
donation histories were retained during the HIV screen-
ing process, owing to concerns from some donors that
they would be discriminated against if identified as HIV-
positive. Some donors who did not participate in the
screening eventually due to worry about discrimination.
With improvements in the HIV monitoring network
from 1996 to 2013, additional HIV-positive plasma do-
nors were identified. Source monitoring indicated that
2053 former paid blood donors were identified as being
HIV-negative between 1990 and 1994. Four individuals
who tested positive for HIV in 1995 were found to have
been infected with HIV through blood transfusions (no
other risk factors) received in October 1994; the blood
donor was HIV-negative at the time of supplying the
blood, but later tested HIV-positive [5]. Blood specimens
from 45 blood recipients who received blood transfusion
from January 1993 to September 1994 tested as HIV-
negative.
Regarding the causes of the HIV outbreak in Hebei
Province, before 1995, HIV-positive individuals could
enter the blood plasma collection process with no required
HIV testing. Single-donor plasma collection included two
cycles of whole blood collection, plasma separation and
blood cell return to the donor. Physiological saline, med-
ical scissors, hemostatic forceps, centrifuges, catheters and
other instruments were shared among plasma donors. Es-
pecially in the plasma separation room, the sharing of in-
struments between donors and medical workers results in
widespread cross-contamination of blood plasma in the
plastic catheters connected to blood bags used during the
process of plasma separation.
General information
During 1995–2013, there were 326 cases identified as
HIV-positive arising from individuals who had donated
blood at plasmapheresis centers in Hebei Province
(Fig. 1). Among these, 94.2 % of individuals were residing
in Langfang, 2.5 % in Chengde, 1.2 % in Handan, 0.9 %
in Tangshan, 0.6 % in Hengshui, 0.3 % in Qinhuangdao,
and 0.3 % resided in Xingtai. As to plasma donation
site, 97.9 % of these individuals had donated blood in
Langfang, 0.6 % in Handan, 0.6 % in Tangshan, 0.3 % in
Hengshui, 0.3 % in Qinhuangdao, and 0.3 % had
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donated in Shijiazhuang. According to data obtained
from tracking the source of infection, HIV infections
first emerged in October 1994 [5]. All plasmapheresis
centers were closed in April 1995; therefore, the transmis-
sion period was approximately 6 months. In the city of
Langfang, the major transmission site, all plasmapheresis
centers were closed in February 1995; therefore, the trans-
mission period in Langfang was only 4 months.
Annually reported cases
Among the 326 HIV/AIDS cases, the first case was iden-
tified on 26 January 1995, and the last case was identi-
fied on 28 February 2012. After the living subsidy policy
was enacted in January 2012 for previously reported
blood transmission cases, two plasma donor-related
cases were diagnosed on 23 and 28 February 2012, in
two individuals born in 1972 and 1971, respectively.
Both of these cases were male, and their CD4 cell counts
were 3 cells/mm3 and 85 cells/mm3, respectively, at
diagnosis. Through 31 December 2013, no plasma
donor-related HIV/AIDS cases had been diagnosed for a
successive 22 months (651 days). The cases identified
between 1995 and 1998 were all HIV-infected individ-
uals (asymptomatic HIV carriers), and AIDS had begun
to be identified beginning in 1999. As shown in Table 1,
146 cases from the general survey were identified in
1995, accounting for 44.8 % of the total. This data demon-
strates that possibly 55.2 % of paid blood donors did not
participate in the initial screening for various reasons.
Promptness of case identification
Among the 326 HIV-positive cases, 234 cases were HIV-
infected (asymptomatic HIV carriers) when identified,
accounting for 71.8 %; 92 cases had AIDS when identified,
accounting for 28.3 %. We deemed the HIV-positive cases
identified in 1995 to be those cases identified in the same
year as infection, with a total of 146 (44.8 %). The number
of cases identified >1 year (after 1996) after infection was
180 (55.2 %), >5 years (after 2000) after infection was 170
(52.2 %), and >10 years (after 2005) after infection was 88
(27.0 %). Of those HIV cases identified in the same year as
infection, 100 % (146/146) were asymptomatic HIV
carriers. Of the HIV cases identified 1–4 years after
infection, 90 % were asymptomatic HIV carriers (9/10). Of
those cases identified 5–9 years after infection, 65.85 %
were asymptomatic HIV carriers (54/82). Finally, of those
cases identified 10–14 years after infection, 28.4 % were
Fig. 1 Area distribution of plasma-related HIV/AIDS cases in Hebei Province. Map a is a distribution of the residence locations of cases, and map
b is that of plasma donation sites
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Table 1 Identification, survival and death rate of plasma-related HIV/AIDS cases from 1995 to 2013































(a) (b) (c) (d) (e) (f) (g) (h) (i) (j) (k)
1995 146 146 0 146 0 0.0 0 0.0 100.0 0 0.0
1996 1 1 0 147 0 0.0 0 0.0 100.0 0 0.0
1997 0 0 0 147 2 1.4 2 0.6 99.4 0 0.0
1998 2 2 0 147 2 1.4 4 1.2 98.8 0 0.0
1999 7 6 1 152 4 2.6 8 2.5 97.6 0 0.0
2000 16 14 2 164 9 5.5 17 5.2 94.8 0 0.0
2001 10 7 3 165 11 6.7 28 8.6 91.4 0 0.0
2002 10 7 3 164 18 11.0 46 14.1 85.9 0 0.0
2003 13 7 6 159 18 11.3 64 19.6 80.4 16 10.1
2004 33 19 14 174 24 13.8 88 24.5 75.5 47 27.0
2005 36 13 23 186 26 14.0 114 35.0 65.0 60 32.3
2006 14 7 7 174 8 4.6 122 37.4 62.6 63 36.2
2007 8 0 8 174 9 5.2 131 40.2 59.8 88 50.6
2008 9 1 8 174 13 7.5 144 44.17 55.8 97 55.8
2009 6 0 6 167 11 6.6 155 47.6 52.5 109 65.3
2010 7 2 5 163 6 4.7 161 49.4 50.6 115 70.6
2011 6 2 4 163 9 5.5 170 52.2 47.9 124 76.1
2012 2 0 2 156 4 2.6 174 53.4 46.6 127 81.4
2013 0 0 0 152 5 3.3 179 54.9 45.1 127 83.6














asymptomatic HIV carriers (25/88). These data are sum-
marized in Table 1, and in Figs. 2 and 3.
Survival rate
From all-cause mortality results measured in the year of
infection, the data indicate that deaths began to occur in
1997 (mortality 1.4 %). Peak mortality took place from
2000 to 2005 (i.e., 6–10 years after infection). Up to
2013, the cumulative number of deaths was 179, a cu-
mulative mortality rate of 54.9 %. Cumulative survival
was 147 cases, a survival rate of 45.1 %. The mortality,
cumulative mortality, and cumulative survival rate
curves from 1995–2013 are shown in Table 1 and Fig. 3.
Sexual transmission between couples
Among the 326 HIV/AIDS cases, 14 cases (3.1 %) were
unmarried at the time they were informed of infection.
Of the 312 HIV/AIDS cases who were married, the
number of involved spouses or regular sexual partners
was 314 (one infected individual had three sexual part-
ners). Excluding 66 spouses who were not tested, 176
spouses had a history of exposure to a plasma donation.
One spouse had sexual transmission outside of marriage,
71 spouses met the monitoring conditions for couple
transmission, and 8 spouses tested positive for HIV anti-
body. Overall, the couple transmission rate was 11.3 %.
Among the initial HIV/AIDS cases identified in 1995 (in
the same year as infection), there were 30 cases of
spouses who met the monitoring conditions for couple
transmission. Until 2013, there was one case of couple
transmission, and the transmission rate was 3.3 %.
Among the HIV/AIDS cases identified from 1999 to
2012 (4–17 years after infection), there were 41 cases of
spouses who met the monitoring conditions for couple
transmission. Until 2013, there were seven cases of
couple transmission and the transmission rate was
17.1 %, shown in Table 2.
Mother-to-infant transmission
Among the 326 plasma donor-related HIV/AIDS cases,
there were 171 female cases, 170 married cases, and 11
cases (6.6 %) that were not investigated after detection
of HIV infection. Among another 159 female HIV/AIDS
cases who were married and capable of bearing children,
145 individuals (91.2 %) did not have any children after
being informed of HIV infection and 14 individuals
(8.8 %) gave birth to a total of 19 children after being in-
formed of infection. Blood samples were collected from
13 children of women infected with HIV and test, and
five children tested positive for HIV antibody. The
mother-to-infant transmission rate was 38.5 %, as shown
in Table 2. The mothers of the five HIV-positive children
were themselves identified as infected with HIV on 26
February and 6 March 1995, 2 March 2001, 1 April
Fig. 2 Distribution of plasma donor-related HIV/AIDS cases reported from 1995 to 2013 in Hebei Province
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2002, and 7 June 2006. The five children were born on
10 February 1995, 1 August 2007, 7 March 2001, 22
March 1996 and 18 May 2003, and were identified to be
HIV-positive on 4 March 2004, 8 April 2009, 5 July
2003, 2 April 2005 and 2 April 2005, respectively. All
mother-to-infant transmission cases appeared prior to
the start of mother-to-infant HIV transmission preven-
tion policies adopted in local regions.
To trace the possibility of HIV-positive males trans-
mitting HIV to their spouses and subsequently to their
children via mother-to-infant transmission, we carried
out an analysis of the 155 male plasma donor-related
cases. We investigated possible transmission factors for
the 144 spouses of the 142 married cases therein and
found that 76 cases had histories of plasma donation,
ten cases were not investigated, one case had engaged in
extramarital sexual behavior, one case had no possible
transmission route and another 56 female spouses in
which couple transmission was the sole transmission
factor. Among these 56 female spouses, 42 consented to
HIV testing and five were found to be HIV-positive.
Four female spouses did not bear any children after be-
ing informed of infection with HIV, and one did not
consent to HIV testing. Third-generation transmission
to infected children via mother-to-infant transmission
was not detected.
Antiviral therapy
With respect to HAART measures begun in 2003, cover-
age was relatively low owing to an insufficient supply of
antiviral drugs in the early stages of the government pro-
gram. With the increased number of patients, improved
antiviral drug supply, and modified therapeutic strategy,
the HAART coverage rate has increased over time and
the death rate has declined. Approximately 45.1 % of
HIV/AIDS patients have survived 18 years after infection
with HIV, as shown in Table 1 and Fig. 3.
HIV and subtypes
All 326 plasma donor-related HIV/AIDS cases and
second-generation cases were infected with HIV-1. PCR
amplification was conducted for blood samples from
seven cases; the PCR products were then sequenced and
used to create a phylogenetic tree, seen in Fig. 4. The
prevalent HIV-1 strain belongs to B’ subtype, particularly
in combination with Yunnan Ruili strain RL42 env (Thai
subtype B).
Discussion
In early 1983, Gury reported HIV infections among paid
blood donors [6], but the report did not draw attention
to infection among paid blood donors at a global level.
As a result, the prevalence of HIV infection among paid
Fig. 3 HAART coverage rate and changes in cumulative survival rate, cumulative mortality rate, mortality rate and antiviral therapy, from 1995 to
2013 in Hebei Province
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blood donors continued to increase globally. In 1985,
Wendel et al. reported HIV infections among paid blood
donors in Brazil [7]. Until 1995, similar infections had
been reported in Greece, Western Germany, California
in the United States, Mexico, India, Spain, Thailand,
Cambodia, Zaire and Nigeria [8–10]. In 1985 and 1993,
hepatitis C virus and malaria were found to be prevalent
among plasma donors in Hebei Province in China [1–3],
and the clear conclusion was drawn that the cause was
cross-infection during blood collection. However, the
prevalence of HIV in this population was not established
until 1995.
In 1995, when HIV was discovered to be prevalent
among plasma donors in Hebei, all plasmapheresis cen-
ters in the province were closed that same year. Subse-
quently, the prevalence of HIV acquired from cross-
infection among blood donors ceased immediately.
However, owing to the long incubation period of AIDS,
social discrimination, and panic related to the disease,
several donors concealed their histories as former paid
blood donors so they were not included in the initial
HIV screening conducted in 1995. Therefore, from 1996
to 2012, plasma donor-related HIV/AIDS cases were still
being identified. In particular, between 2000 and 2006,
HIV-infected donors entered the symptomatic period of
disease. Because clinicians had been widely trained and
the HIV monitoring network had gradually improved, in
combination with collective screening activity from De-
cember 2004 to February 2005, the identification of
HIV/AIDS cases peaked from 2000 to 2006. After
18 years of monitoring, 326 HIV/AIDS cases have been
found to be related to blood plasma donation at plasma-
pheresis centers in Hebei Province. Additionally, 8 cases
originated from couple transmission and five cases from
mother-to-infant transmission. Second-generation dis-
ease transmission accounted for 4.0 % of cases. The total
number of first- and second-generation cases is 339. All
first- and second-generation plasma donor-related HIV/
AIDS cases were infected with HIV-1.
The overall couple transmission rate in plasma donor-
related HIV/AIDS cases was 11.3 %. In 1995, in the
same year as infection, the couple transmission rate was
3.3 %. The couple transmission rate in cases identified
4–17 years after infection was 17.1 %. The couple trans-
mission rate of the former was approximately 80.5 %
lower than that of the latter. Couple transmission rates
in cases identified 4–17 years after infection were con-
sistent with the natural couple transmission rate of
17.3 % in situations of ignorance about HIV status [11].
This demonstrates that being informed earlier about the
Table 2 Couple transmission and mother-to-infant transmission in plasma donor-related HIV/AIDS cases
Year Couple transmission detection Mother-to-infant transmission detection











1995 30 1 2 2
1996 0 0 0 0
1997 0 0 0 0
1998 0 0 0 0
1999 2 0 0 0
2000 5 3 0 0
2001 5 0 1 1
2002 0 0 2 1
2003 3 0 0 0
2004 7 1 0 0
2005 6 0 3 0
2006 5 1 4 1
2007 2 0 1 0
2008 0 0 0 0
2009 3 0 0 0
2010 1 0 0 0
2011 1 1 0 0
2012 1 1 0 0
2013 0 0 0 0
Total 71 8 13 5
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HIV-positive status of the spouse or sexual partner is fa-
vorable for the HIV-negative partner to change their
sexual behavior, thereby reducing the risk of HIV trans-
mission. Therefore, it is clear that early identification
and early notification with respect to HIV infection plays
an important role in controlling HIV transmission. Of
single cases, 3.1 % remained unmarried after being in-
formed of HIV infection, which also effectively pre-
vented the occurrence of couple transmission.
This study also revealed that 91.2 % of married female
plasma donor-related HIV cases did not bear children
after being informed of infection, which largely de-
creased the chances of mother-to-infant transmission.
Therefore, diagnosis in the early stages of infection may
reduce the occurrence of mother-to-infant transmission.
In situations where the mother was ignorant about her
HIV-positive status and did have children, the mother-
to-infant transmission rate was 38.5 %. According to
Chen et al., in situations where mother-to-infant transmis-
sion prevention measures were not applied, the mother-
to-infant transmission rate of mothers infected by blood
transfusion was 32.1 % [12]. According to Scarlatti et al.,
approximately 11.0 %–60.0 % of HIV-positive pregnant
women demonstrate mother-to-infant transmission. This
rate has been reported as 20.0 %–30.0 % in the United
States, 15.0 % in Europe, and 50.0 % in Africa [13]. Ac-
cording to Li Guanhan [14], the mother-to-infant trans-
mission rate of HIV-1 is 35.0 % in ten provinces in China.
This result is nearly identical to a report suggesting that
the rate is 41.7 % in Henan Province, 33.3 % in Yunnan
Province, 27.3 % in Xinjiang Province [14].
Until 2013, the cumulative mortality rate and survival
rate of plasma donor-related HIV/AIDS cases was 54.9
% and 45.1 %, respectively. Owing to ongoing improve-
ments in HAART coverage, the survival period for HIV-
positive individuals has been extended. Before HAART
measures were instituted, the average survival time for
former blood donors infected with HIV was 9.58 years
[15], and that of HIV-infected blood transfusion recipi-
ents was 9.92 years [16]. Once the rate of HAART cover-
age had reached 70.6 % of all HIV cases, 50.6 % of these
cases had survived until 15 years after infection. When
the HAART coverage rate reached 83.6 % of all HIV
cases, 45.1 % of these cases survived until 18 years after
infection. According one study in Uganda, it was found
that if the patient’s CD4 levels exceeded 150 cells/mm3,
HAART treatment would extend life expectancy to
nearly that of a normal healthy individual [17]. Thus, it
is clear that early therapy and enhancing the HAART
coverage rate can greatly decrease the mortality rate and
extend the life span of HIV-infected individuals.
Conclusions
In this accident of HIV-infection among plasma donors
in Hebei Province, a total of 339 direct and second-
generation cases have been identified over 18 years of
monitoring. Favorable clinical results have been achieved
using intervention measurements and antiviral therapy.
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